Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period
在以色列，AZD7442（Tixagevimab/Cilgavimab）用于预防 COVID-19 住院治疗的有效性（Omicron 亚型时期）
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-01100-3
Hayek, Samah; Levy, Joseph; Shaham, Galit; Dagan, Noa; Serby, Danielle; Duskin-Bitan, Hadar; Dube, Sabada; Ferreira, Cátia; Livnat, Idit; Talarico, Carla; Taylor, Sylvia; Venkatesan, Sudhir; Yarden, Adva; Balicer, Ran D; Netzer, Doron; Peretz, Alon
